Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

2001

Stage

Series A | Alive

Total Raised

$4.99M

Last Raised

$4.99M | 17 yrs ago

About ReceptIcon

Developer of kidney receptor antagonists. The company develops antagonists designed to prevent the accumulation of therapeutics in the kidney, which can be used as active pharmaceutical ingredients (APIs) for the reformulation of nephrotoxic drugs without toxic side effects.

ReceptIcon Headquarters Location

Gustav Wieds Vej 10 Aarhus C

Copenhagen, 8000,

Denmark

45 86 20 51 94

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ReceptIcon

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ReceptIcon is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

  • When was ReceptIcon founded?

    ReceptIcon was founded in 2001.

  • Where is ReceptIcon's headquarters?

    ReceptIcon's headquarters is located at Gustav Wieds Vej 10, Copenhagen.

  • What is ReceptIcon's latest funding round?

    ReceptIcon's latest funding round is Series A.

  • How much did ReceptIcon raise?

    ReceptIcon raised a total of $4.99M.

  • Who are the investors of ReceptIcon?

    Investors of ReceptIcon include Dansk Erhvervsinvestering, Ostjysk Innovation and Vecata.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.